Literature DB >> 11883897

Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1.

Ramiro Barcia1, Susana López-Borges, Francisco M Vega, Pedro A Lazo.   

Abstract

The vaccinia-related kinase 1 (VRK1) protein is a nuclear Ser-Thr kinase that phosphorylates p53 in Thr18. We have determined the enzyme properties regarding its different substrates. VRK1 has a high affinity for ATP (K(m) 50 microM) and is thus saturated by the intracellular concentration of ATP in vivo. VRK1 uses preferentially magnesium, but is also functional with manganese and zinc. The VRK1 protein is autophosphorylated in multiple residues without effect on its activity. One autophosphorylated residue, T355, is within the VRK1 regulatory carboxy terminus. The kinase phosphorylates p53 with a K(m) of 1 microM and is well suited to respond to the variations of intracellular p53 concentration, which fluctuates as a response to different types of cellular stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883897     DOI: 10.1006/abbi.2001.2746

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  25 in total

1.  Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase.

Authors:  Wanil Kim; Goutam Chakraborty; Sangjune Kim; Joon Shin; Choon-Ho Park; Min-Woo Jeong; Nagakumar Bharatham; Ho Sup Yoon; Kyong-Tai Kim
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

2.  Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation.

Authors:  Inmaculada López-Sánchez; Marta Sanz-García; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

3.  Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Authors:  Marta Sanz-García; Diana M Monsalve; Ana Sevilla; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

4.  p53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop.

Authors:  Alberto Valbuena; Francisco M Vega; Sandra Blanco; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 5.  Biomarkers of head and neck cancer, tools or a gordian knot?

Authors:  Evangeli S Lampri; Georgios Chondrogiannis; Elli Ioachim; Anna Varouktsi; Antigoni Mitselou; Aggeliki Galani; Evangelos Briassoulis; Panagiotis Kanavaros; Vasiliki Galani
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia.

Authors:  Matthew S Wiebe; R Jeremy Nichols; Tyler P Molitor; Jill K Lindgren; Paula Traktman
Journal:  Biol Reprod       Date:  2009-08-19       Impact factor: 4.285

7.  The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.

Authors:  R Jeremy Nichols; Matthew S Wiebe; Paula Traktman
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

8.  Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2.

Authors:  Marta Vázquez-Cedeira; Pedro A Lazo
Journal:  J Biol Chem       Date:  2012-10-26       Impact factor: 5.157

9.  Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1.

Authors:  Sandra Blanco; Claudio Santos; Pedro A Lazo
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

10.  Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase.

Authors:  Kathleen A Boyle; Paula Traktman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.